Exploratory secondary analysis of an RCT in 314 adults with opioid use disorder: extended-release buprenorphine vs methadone/sublingual buprenorphine gave more opioid-free days (58.5 vs 48.9; IRR 1.20), mainly via direct pathways; reduced opioid 'need' craving partly mediated it.
Secondary analysisn = 314
Marsden et al. Craving and personal functioning as mediators of extended-release buprenorphine efficacy: A four-way decomposition analysis from a randomised trial